Mark Semenuk

486 total citations
8 papers, 384 citations indexed

About

Mark Semenuk is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Mark Semenuk has authored 8 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Mark Semenuk's work include Immune Response and Inflammation (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and interferon and immune responses (2 papers). Mark Semenuk is often cited by papers focused on Immune Response and Inflammation (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and interferon and immune responses (2 papers). Mark Semenuk collaborates with scholars based in United States, Italy and Canada. Mark Semenuk's co-authors include Bernardetta Nardelli, David W. LaFleur, Paul A. Moore, Guoxian Chen, Ping Feng, Diana Chinchilla, Paula M. Pitha, Timothy A. Coleman, Steven M. Ruben and Devanshi S. Shah and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Cancer Research.

In The Last Decade

Mark Semenuk

8 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Semenuk United States	5	288	131	76	75	49	8	384
Serena Chang United States	8	235 0.8×	100 0.8×	157 2.1×	73 1.0×	22 0.4×	17	423
Fanching Lin United States	7	210 0.7×	83 0.6×	80 1.1×	97 1.3×	22 0.4×	13	462
Mónika Ádori Sweden	11	254 0.9×	106 0.8×	68 0.9×	90 1.2×	30 0.6×	28	422
Christopher T. Haley United States	9	120 0.4×	103 0.8×	88 1.2×	61 0.8×	49 1.0×	16	317
Uyen Ngoc Mui United States	10	114 0.4×	101 0.8×	105 1.4×	74 1.0×	50 1.0×	17	372
Daniel Shu United States	6	143 0.5×	107 0.8×	98 1.3×	84 1.1×	25 0.5×	15	319
Nancy Van Houten United States	13	558 1.9×	69 0.5×	64 0.8×	130 1.7×	39 0.8×	19	773
Sarah Van Scoy United States	6	286 1.0×	183 1.4×	92 1.2×	188 2.5×	28 0.6×	6	497
Javier O. Valenzuela United States	4	707 2.5×	212 1.6×	77 1.0×	133 1.8×	20 0.4×	4	811
Tetsu Nishiwaki Japan	7	409 1.4×	64 0.5×	123 1.6×	104 1.4×	14 0.3×	8	626

Countries citing papers authored by Mark Semenuk

Since Specialization

Citations

This map shows the geographic impact of Mark Semenuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Semenuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Semenuk more than expected).

Fields of papers citing papers by Mark Semenuk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Semenuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Semenuk. The network helps show where Mark Semenuk may publish in the future.

Co-authorship network of co-authors of Mark Semenuk

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Semenuk. A scholar is included among the top collaborators of Mark Semenuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Semenuk. Mark Semenuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Semenuk, Mark, et al.. (2017). Abstract 723: Improved detection of cancer specific serum exosomal aspartyl (asparaginyl) beta hydroxylase (HAAH). Cancer Research. 77(13_Supplement). 723–723. 2 indexed citations

2.

Fuller, Steven A., et al.. (2013). Immunogenicity of a lambda phage-based anti-cancer vaccine targeting HAAH. Journal for ImmunoTherapy of Cancer. 1(Suppl 1). P210–P210. 1 indexed citations

3.

Semenuk, Mark, Timothy D. Veenstra, Mark Rochman, et al.. (2011). Translating Cancer Biomarker Discoveries to Clinical Tests: What should be Considered?. 1(3). 222–240. 3 indexed citations

4.

Wan, Xiaochun, Guixiu Shi, Mark Semenuk, Jun Zhang, & Jiangping Wu. (2003). DcR3/TR6 modulates immune cell interactions. Journal of Cellular Biochemistry. 89(3). 603–612. 20 indexed citations

5.

Nardelli, Bernardetta, Liubov Zaritskaya, Mark Semenuk, et al.. (2002). Regulatory Effect of IFN-κ, A Novel Type I IFN, On Cytokine Production by Cells of the Innate Immune System. The Journal of Immunology. 169(9). 4822–4830. 66 indexed citations

6.

LaFleur, David W., Bernardetta Nardelli, Ping Feng, et al.. (2001). Interferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes. Journal of Biological Chemistry. 276(43). 39765–39771. 211 indexed citations

7.

Nardelli, Bernardetta, et al.. (1999). Dendritic cells and MPIF-1: chemotactic activity and inhibition of endogenous chemokine production by IFN-γ and CD40 ligation. Journal of Leukocyte Biology. 65(6). 822–828. 26 indexed citations

8.

Bhattacharjee, A. K., Steven M. Opal, Robert M. Taylor, et al.. (1996). A Noncovalent Complex Vaccine Prepared with Detoxified Escherichia coli J5 (Rc Chemotype) Lipopolysaccharide and Neisseria meningitidis Group B Outer Membrane Protein Produces Protective Antibodies against Gram-Negative Bacteremia. The Journal of Infectious Diseases. 173(5). 1157–1163. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact